• Biogen
  •  Overview
  • Last Modified:
  • March 10, 2025
  • Company type:
  • Public
  • Industry:
  • Healthcare
  • Verified:
  • No
  • No of Employees:
  • 1 001 - 10 000
  • Stock Code:
  • BIIB
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • Cambridge, Massachusetts
  • Public Interest Score:
  • 750+

 

  • Biogen
  • General Information

Description

Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world. Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.

Caroline Dorsa:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Maria Freire:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
William Hawkins:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Susan Langer:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jesus Mantas:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Lloyd Minor:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Menelas Pangalos:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Monish Patolawala:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Eric Rowinsky:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Stephen Sherwin:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Christopher A. Viehbacher:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 14870
  • Founded Year: 
  • 1978
  • Registration Number: 
  • 33-0112644
  • Country: 
  • United States of America
  • Stock Exchanges: 
    • NASDAQ Stock Exchange
  • Financial year end: 
  • December
  • No. of Countries operations: 
  • 6
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Drug Manufacturers—General
  • Date listed on Stock Exchange: 
  • 12/01/2017

 

  • Contact Information
  • Business operation: 
  • Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients' lives.
  • Primary office: 
  • Cambridge, Massachusetts

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Susan H. Alexander
  • Reporting currency: 
  • USD
  • ISIN number (12 digit): 
NASDAQ
US09062X1037
  • Authorised shares:
  • 9 000 000
  • Issued shares:
  • 170 800
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 0 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
Moody'sUnited States of AmericaNew YorkAAA
S&PUnited States of AmericaNew YorkAA+

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Caroline

Non Executive
NationalityAmerican
67
RoleNED
QualificationMBA,BA
Date Appointed: 01/01/2010
Duration:
16 years and 8 months
Independance: N
Profile
Name

Maria C

Non Executive
NationalityAmerican
RoleNED
QualificationPh.D. in Biophysics
Date Appointed: 01/01/2021
Duration:
5 years and 8 months
Independance: Y
Profile
Name

William A

Non Executive
NationalityAmerican
RoleNED
QualificationElectrical and Biomedical Engineering, MBA
Date Appointed: 01/01/2019
Duration:
7 years and 8 months
Independance: Y
Profile
Name

Susan

Non Executive
NationalityAmerican
RoleNED
QualificationBachelor of Arts degree
Date Appointed: 01/01/2023
Duration:
3 years and 8 months
Independance: Y
Profile
Name

Jesus B

Non Executive
NationalityAmerican
RoleNED
QualificationNot Available
Date Appointed: 01/01/2019
Duration:
7 years and 8 months
Independance: Y
Profile
Name

Lloyd

Non Executive
NationalityAmerican
69
RoleNED
QualificationB.S, M.D.
Date Appointed: 01/01/2024
Duration:
2 years and 8 months
Independance: Y
Profile
Name

Menelas

Non Executive
NationalityUnited Kingdom
RoleNED
QualificationPh.D.
Date Appointed: 01/01/2025
Duration:
1 year and 8 months
Independance: Y
Profile
Name

Monish

Executive
NationalityIndia
65
RoleCFO
QualificationCertified Chartered Accountant and a Certified Cost Accountant
Date Appointed: 01/01/2024
Duration:
2 years and 8 months
Independance: Y
Profile
Name

Eric K

Non Executive
NationalityAmerican
RoleNED
QualificationPhD
Date Appointed: 01/01/2010
Duration:
16 years and 8 months
Independance: N
Profile
Name

Stephen A

Non Executive
NationalityAmerican
RoleNED
QualificationPhD
Date Appointed: 01/01/2010
Duration:
16 years and 8 months
Independance: N
Profile
Name

Christopher A.

Executive
NationalityGermany
RoleCEO
QualificationPA
Date Appointed: 01/11/2022
Duration:
3 years and 10 months
Independance: Y
Profile

 

Directors Tenure

Name
Duration
Name

Caroline Dorsa

Duration16 years and 8 months
Profile
Name

Maria C Freire

Duration5 years and 8 months
Profile
Name

William A Hawkins

Duration7 years and 8 months
Profile
Name

Susan Langer

Duration3 years and 8 months
Profile
Name

Jesus B Mantas

Duration7 years and 8 months
Profile
Name

Lloyd Minor

Duration2 years and 8 months
Profile
Name

Menelas Pangalos

Duration1 year and 8 months
Profile
Name

Monish Patolawala

Duration2 years and 8 months
Profile
Name

Eric K Rowinsky

Duration16 years and 8 months
Profile
Name

Stephen A Sherwin

Duration16 years and 8 months
Profile
Name

Christopher A. Viehbacher

Duration3 years and 10 months
Profile

 

Director Experience

Name
Experience
Name

Caroline

Experience Telecom, Pharmaceutical
Profile
Name

Maria C

Experience Healthcare
Profile
Name

William A

Experience Pharmaceutical, Healthcare
Profile
Name

Susan

Experience Healthcare
Profile
Name

Jesus B

Experience Technology, Financial Services
Profile
Name

Lloyd

Experience Education
Profile
Name

Menelas

Experience Healthcare
Profile
Name

Monish

Experience Financial Services
Profile
Name

Eric K

Experience Healthcare
Profile
Name

Stephen A

Experience Healthcare
Profile
Name

Christopher A.

Experience Healthcare, Pharmaceutical
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

PwC

Date Appointed01/01/2003
Year23 years and 8 months
Profile

 

 

Company Committees

Name

Caroline Dorsa

Mainboard, Audit, Remuneration BD, NG
Profile
Name

Maria C Freire

Mainboard, Audit, Remuneration BD, RE
Profile
Name

William A Hawkins

Mainboard, Audit, Remuneration BD, AU, NG
Profile
Name

Susan Langer

Mainboard, Audit, Remuneration BD
Profile
Name

Jesus B Mantas

Mainboard, Audit, Remuneration BD, AU, RE
Profile
Name

Lloyd Minor

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Menelas Pangalos

Mainboard, Audit, Remuneration BD, RE
Profile
Name

Monish Patolawala

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Eric K Rowinsky

Mainboard, Audit, Remuneration BD, RE, NG
Profile
Name

Stephen A Sherwin

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Christopher A. Viehbacher

Mainboard, Audit, Remuneration BD
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT